Latest Rosemont Pharmaceuticals Ltd. Stories
DUBLIN, Feb. 6, 2014 /PRNewswire/ -- -- Fiscal second quarter net sales increased 11% year-over-year to a record $979 million. -- Fiscal second quarter adjusted net income increased 45% to a record $185 million, or $1.87 per diluted share. -- Fiscal second quarter GAAP net loss of $86 million or ($0.87) per diluted share, due primarily to $269 million of acquisition-related charges, including loss on extinguishment of debt. -- Record...
- The navel or umbilicus.
- In Greek archaeology: A central boss, as on a shield, a bowl, etc.